NuVasive to Acquire Biotronic NeuroNetwork

SAN DIEGO, CA--(Marketwired - June 06, 2016) -

• Enhances NuVasive's Spine Service Line Partnership Offerings
• Doubles Size of NuVasive's Service Platform with Complementary Geographic Footprint
• Expanded Platform Drives Greater Utilization and Integration of NuVasive's Procedurally-Integrated Portfolio
• Immediately Accretive to Non-GAAP Diluted Earnings, Aligned to Operating and EBITDA Margin Expansion

NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery, and Biotronic NeuroNetwork ("Biotronic"), a provider of intraoperative neurophysiological monitoring services, today announced that they have entered into a definitive agreement under which NuVasive will acquire Biotronic for $98 million in cash. The Board of Directors of both companies have unanimously approved the transaction.

Enhancing Spine Service Line Partnerships

The acquisition of Biotronic advances NuVasive's strategy to transform how spine procedures are approached, measured and valued from a clinical and economic perspective, by:

• Delivering Clinical Fulfillment: The acquisition enhances NuVasive's spine service line partnership offering for health system customers, by supporting clinical fulfillment through enhanced surgical monitoring and oversight capabilities.
• Doubling NuVasive's Service Footprint: With the acquisition of Biotronic, NuVasive will double the footprint of its service business across the U.S. and grow coverage and capabilities in key, complementary markets.
• Creating the Standard of Care: NuVasive will be able to further deliver a consistently high standard of care and increase the breadth of differentiated products and services offered to health systems as they seek to build out their spine service line, improving the clinical and economic value of the company's procedurally-integrated offerings.

About Biotronic

Founded in 1982 and privately held, Biotronic is a patient-centric healthcare organization that provides intraoperative neurophysiological monitoring services to surgeons and healthcare facilities across the U.S. Biotronic helps surgeons reduce surgical variability and improve clinical outcomes by providing certified specialists to monitor patients' nervous system during surgery, while also offering remote physician oversight. Biotronic supports more than 45,000 surgeries annually in more than 650 hospitals, providing real-time remote monitoring through proprietary software and a secure, virtual private network. With more than $50 million in revenue in 2015, Biotronic is positioned as a premium provider in the intraoperative monitoring market.